Biologic Therapies bursts onto orthobiologics scene

Welcome back to the Medical Technology Blog. We start off the week with an article from the orthopaedics business, please read on…

A new company has been propelled into the orthobiologics industry as the result of a joint venture between device firms Scorpion Medical and Monet Medical. Dubbed Biologic Therapies, the new company will focus on the design, development and manufacture of components for the biologics sector of the medical device industry.

Orthobiology is the inclusion of biology and biochemistry in the development of bone and soft tissue replacement materials for skeletal and tissue healing. Biologic Therapies  will  attempt to take this process to a new level by creating ‘Autologous Orthobiologic Therapy’. The company believes it can use the body’s own stem cells to increase the healing potential and provide quicker restoration of function within muscle, tendon, ligament, bone and cartilage, said Dr R Wade McKenna, owner and operator of Monet Medical and  by an orthopaedic surgeon. Biologic Therapies will be led by President Steve Bales, a former employee of DePuy and Encore Medical.

McKenna’s autologous biologic therapy (bone marrow aspirate stem cells) treatments are designed to augment overall healing and improve surgical and non-surgical results. The treatments are for ligamentous injuries involving the knee, ankle and elbow. Treatments in the knee include ACL, MCL and LCL injuries. In the elbow, stem cells are used successfully to treat acute and chronic medial and lateral epicondylitis. Ligamentous injuries around the ankle are referred to as sprains but can often represent significant tears to the stabilising structures of the ankle. Autologous biologic therapy is used around the ankle in chronic and acute sprains to shorten the recovery time and improve the quality of healing tissue.

As its first product offering, Biologic Therapies is actively working to bring to market a new, patented device for accessing a patient’s own stem cells through the safe and painless harvest of bone marrow. This device is scheduled for market release during the first quarter of 2012. The company believes this device is unlike anything currently available and expects it could become the “gold-standard” for use in stem cell harvesting procedures.

Closely following the stem cell harvesting device will be a range of implant systems for fracture fixation, which will include the ability to introduce stem cells precisely at the fracture site. In addition, Biologic Therapies intends to create a strategic initiative to broaden the training and product support by offering an educational element to surgeons and healthcare professionals. The educational programme will aim to enhance the awareness and efficacy of this emerging technology as well as share Biologic Therapies’ surgical protocols designed to increase the success rate of autologous orthobiologic therapies.

Thanks to Sophie Bracken for providing this article, Sophie edits Espicom’s business publication Orthopaedics Business News.

Related articles

• Zimmer’s cash-saving scheme begins with Statesville site closure (medical-technologyblog.com)
• CellSonic seeks global distribution for lithotripter product line (medical-technologyblog.com)
• Scientists use tumour’s ‘fingerprint’ to test for rare cancer (medical-technologyblog.com)

Tagged with: biologic knee therapy • biologic stem cell therapy + knee • biologic therapies bursts onto orthobiologics scene • biologic therapies medical • biologic therapies scorpion • biologics patents for bone repair • blog stem cell on knee • bone marrow aspirate biologics • bone tissue healing technology market • Clinical trial • DePuy • depuy harvest stem cells • depuy stem cell • depuy symphony stem cell • depuy trauma • depuy trauma line • depuy v. zimmer • dr. r. wade mckenna • dr. wade mckenna • flector patch pcl sprain • Food & Drug Administration • Health • ketotransdel clinical trials presentation • market for bone marrow aspirate • market size for marrow harvesting • medical device • Medical Technology • Medicine • orthobiologics suppliers • orthopaedics business news • stem cell medical technology • Steve Bales • zimmer biologics • zimmer vs depuy

Filed under: Medical Technology

Like this post? Subscribe to my RSS feed and get loads more!